BioNTech speaks of ‘complex network’ of production for vaccine
The German Covid-19 vaccine manufacturer BioNTech has a complex network of manufacturing capabilities in Europe and there is also the Pfizer network in the United States.
BioNTech: Vaccine likely also effective against new variants
Even if the coronavirus has mutated, German vaccine manufacturer BioNTech still believes that it is highly likely it can be combatted effectively. Company boss Ugur Sahin is considering new production facilities for the vaccine so that orders can be delivered earlier.